• Centers and Programs
  • Alzheimer's Disease Center
  • Center for Brain Injury and Repair
  • Center for Cognitive Neuroscience
  • Center for Functional Neuroimaging
  • Center for Sleep and Respiratory Biology
  • Center for Spirituality and the Mind
  • Mahoney Institute of Neurological Sciences
  • Multiple Sclerosis Program
  • Neuro-Ophthalmology Program
  • Smell and Taste Center
  • Vision Research Center
• Clinical Trials
  • Cognitive Neurology (Memory Disorders)
  • Epilepsy
  • Herpes Simplex Encephalitis
  • Multiple Sclerosis
  • Neuromuscular
  • Neuro-Oncology
  • Parkinson's Disease / Movement Disorders
  • Acute Stroke
  • Stroke Prevention

   

Double blind study to evaluate efficacy and safety of Rufinamide 3200mg/day (1600mg b.i.d dosing)

Patients having 3 partial onset seizures per month while taking 1-3 AEDs.

Patient will be compensated $40 per visit.